Abstract | BACKGROUND: METHODS: Four hundred and sixty-five patients, aged 18-70 years, were allocated randomly to three groups to receive alfentanil 10 microg/kg, remifentanil 1 microg/kg or an equal volume of 0.9% saline intravenously over 10 s. Any episode of cough was classified as coughing and graded as mild (1-2), moderate (3-4) or severe (5 or more). RESULTS: The overall incidence of cough was higher in the opioid groups than in the saline group. The remifentanil group [39/150 patients; 26.0% (95% CI, 19.6-33.6%)] showed a higher incidence than the alfentanil group [11/152 patients; 7.2% (95% CI, 0.4-12.6%)] (P<0.001). There was no significant difference in the severity of cough between the alfentanil group and the remifentanil group. CONCLUSION:
|
Authors | H B Cho, H J Kwak, S Y Park, J Y Kim |
Journal | Acta anaesthesiologica Scandinavica
(Acta Anaesthesiol Scand)
Vol. 54
Issue 6
Pg. 717-20
(Jul 2010)
ISSN: 1399-6576 [Electronic] England |
PMID | 20085544
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Piperidines
- Alfentanil
- Remifentanil
|
Topics |
- Adult
- Aged
- Alfentanil
(administration & dosage, adverse effects)
- Anesthesia, General
- Cough
(chemically induced, epidemiology)
- Double-Blind Method
- Elective Surgical Procedures
- Female
- Hemodynamics
(drug effects)
- Humans
- Incidence
- Injections, Intravenous
- Male
- Middle Aged
- Models, Neurological
- Piperidines
(administration & dosage, adverse effects)
- Preanesthetic Medication
- Remifentanil
- Severity of Illness Index
|